封面
市场调查报告书
商品编码
1812425

细胞冷冻介质市场:按产品类型、按细胞类型、按冷冻保护剂类型、按应用、按配方、按最终用户、按地区

Cell Freezing Media Market, By Product Type, By Cell Type, By Cryoprotectant Type, By Application, By Formulation, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细胞冷冻培养基市场规模预计在 2025 年达到 19.2 亿美元,预计到 2032 年将达到 36.8 亿美元,2025 年至 2032 年的复合年增长率为 9.73%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 19.2亿美元
效能数据 2020年至2024年 预测期 2020年至2024年
预测期:2025-2032年复合年增长率: 9.73% 2032年的价值预测 36.8亿美元

全球细胞冻存介质市场是生物技术和製药产业的重要组成部分,也是低温储存过程中维持细胞活力的重要保存解决方案。细胞冻存介质,也称为低温保存介质,是一种专门设计的配方,旨在保护细胞结构免受冻融过程中冰晶形成和渗透压的影响。

这些培养基通常含有冷冻保护剂,例如二甲基亚砜(DMSO)、甘油和各种促进细胞在超低温下存活的蛋白质。该市场提供多种产品类型,包括含血清和无血清配方,每种配方均针对特定细胞类型和研究应用量身定制。随着细胞和基因治疗研究、再生医学和生物银行活动的扩展,对高品质细胞冷冻培养基的需求显着增长。该市场服务于各种各样的最终用户,包括製药公司、生物技术公司、研究机构和细胞库,他们需要可靠的储存解决方案来长期保存珍贵的生物样本和治疗细胞,同时确保解冻后细胞的最佳恢復和功能。

市场动态

全球细胞冻存介质市场受到多个关键因素的支撑,这些因素推动了其强劲的成长轨迹。主要驱动力是细胞和基因治疗研究的快速发展,在这些研究中,维持细胞在储存期间的活力对于成功治疗至关重要。慢性病和遗传疾病的日益普及推动了再生医学的研究活动,对有效的冷冻保存解决方案产生了巨大的需求。此外,全球生物样本库数量的不断增加,加上干细胞研究倡议的不断扩展,也对市场成长做出了重大贡献。个人化医疗方法的兴起以及对患者特异性细胞长期储存的需求进一步扩大了需求。

然而,该市场也面临一些限制,例如优质细胞冻存培养基配方高成本,这可能会对小型研究机构和新兴生物技术公司造成负担。冻存培养基中使用动物性成分的监管复杂性也带来了额外的挑战,需要进行广泛的验证过程。此外,品管要求以及针对不同应用的标准化通讯协定也限制了市场准入。

儘管有这些局限性,但无血清培养基和化学成分确定的培养基配方的技术进步为解决安全和监管问题提供了重要机会。在组织工程、器官移植研究和新型治疗方法开发中不断扩展的应用,带来了丰厚的成长机会。此外,新兴经济体对医疗基础设施的投资不断增加,以及自动化冷冻保存系统的日益普及,也为创新细胞冷冻培养基解决方案创造了新的市场机会。

本次调查的主要特点

  • 本报告对全球细胞冷冻培养基市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它揭示了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数概述了全球细胞冷冻培养基市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球细胞冷冻培养基市场报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过分析全球细胞冷冻培养基市场所使用的各种策略矩阵更轻鬆地做出决策。

目录

第 1 章:调查目标与先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章:市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020-2032 年全球细胞冷冻培养基市场(依产品类型)

  • 含血清的冷冻培养基
  • 无血清冷冻培养基
  • 无蛋白冷冻培养基
  • 化学成分确定的冷冻培养基

5. 全球细胞冷冻培养基市场(依细胞型),2020-2032

  • 哺乳动物细胞冷冻培养基
  • 干细胞冷冻培养基
  • 原代细胞冷冻培养基
  • 昆虫细胞冷冻培养基
  • 微生物细胞冷冻培养基

6. 2020 年至 2032 年全球细胞冷冻介质市场(以冷冻保护剂类型)

  • 含DMSO的培养基
  • 无DMSO培养基
  • 甘油基培养基

7. 全球细胞冷冻培养基市场(依应用划分),2020-2032

  • 干细胞保存
  • 组织保存
  • 精子冷冻
  • 卵子/胚胎冷冻
  • 再生医学

8. 全球细胞冷冻培养基市场(依配方),2020-2032

  • RTU处方
  • 客製化/研究级配方

9. 全球细胞冷冻培养基市场(依最终用户划分),2020-2032

  • 製药和生物技术公司
  • 医院和诊断实验室
  • 细胞库和生物检体资料库
  • 合约研究组织(CRO)
  • 其他(学术、研究机构等)

第 10 章。 2020-2032 年按地区分類的全球细胞冷冻培养基市场

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十一章 竞争格局

  • Thermo Fisher Scientific Inc.
  • Cytiva(Danaher Corporation)
  • Merck KGaA(Sigma-Aldrich)
  • Lonza Group AG
  • STEMCELL Technologies Inc.
  • BioLife Solutions Inc.
  • Corning Incorporated
  • HiMedia Laboratories Pvt. Ltd.
  • FUJIFILM Irvine Scientific Inc.
  • MP Biomedicals LLC
  • AMSBIO(AMS Biotechnology)
  • Nacalai Tesque Inc.
  • Cell Applications Inc.
  • Miltenyi Biotec BV and Co. KG
  • Sartorius AG

第 12 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十三章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8434

Cell Freezing Media Market is estimated to be valued at USD 1.92 Bn in 2025 and is expected to reach USD 3.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.73% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.92 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.73% 2032 Value Projection: USD 3.68 Bn

The global cell freezing media market represents a critical component of the biotechnology and pharmaceutical industries, serving as an essential preservation solution for maintaining cell viability during cryogenic storage processes. Cell freezing media, also known as cryopreservation media, are specialized formulations designed to protect cellular structures from ice crystal formation and osmotic stress during the freezing and thawing processes.

These media typically contain cryoprotectants such as Dimethyl Sulfoxide (DMSO), glycerol, and various proteins that facilitate cellular survival at ultra-low temperatures. The market encompasses various product types including serum-containing and serum-free formulations, each tailored to specific cell types and research applications. With the expanding scope of cell and gene therapy research, regenerative medicine, and biobanking activities, the demand for high-quality cell freezing media has witnessed substantial growth. The market serves diverse end-users including pharmaceutical companies, biotechnology firms, research institutions, and cell banks, all requiring reliable preservation solutions to maintain valuable biological samples and therapeutic cells for extended periods while ensuring optimal recovery rates and cellular functionality upon thawing.

Market Dynamics

The global cell freezing media market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver stems from the exponential expansion of cell and gene therapy research, where maintaining cell viability during storage is paramount for successful therapeutic outcomes. The increasing prevalence of chronic diseases and genetic disorders has intensified research activities in regenerative medicine, creating substantial demand for effective cryopreservation solutions. Additionally, the growing number of biobanks worldwide, coupled with expanding stem cell research initiatives, significantly contributes to market growth. The rise in personalized medicine approaches and the need for long-term storage of patient-specific cells further amplifies demand.

However, the market faces certain restraints including the high costs associated with premium cell freezing media formulations, which can burden smaller research institutions and emerging biotechnology companies. Regulatory complexities surrounding the use of animal-derived components in freezing media pose additional challenges, necessitating extensive validation processes. Quality control requirements and the need for standardized protocols across different applications can also limit market accessibility.

Despite these constraints, significant opportunities emerge from technological advancements in serum-free and chemically-defined media formulations, addressing safety and regulatory concerns. The expanding applications in tissue engineering, organ transplantation research, and the development of novel therapeutic modalities present lucrative growth avenues. Furthermore, increasing investments in healthcare infrastructure in emerging economies and the growing adoption of automated cryopreservation systems create new market opportunities for innovative cell freezing media solutions.

Key Features of the Study

  • This report provides in-depth analysis of the global cell freezing media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell freezing media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Merck KGaA (Sigma-Aldrich), Lonza Group AG, STEMCELL Technologies Inc., BioLife Solutions Inc., Corning Incorporated, HiMedia Laboratories Pvt. Ltd., FUJIFILM Irvine Scientific Inc., MP Biomedicals LLC, AMSBIO (AMS Biotechnology), Nacalai Tesque Inc., Cell Applications Inc., Miltenyi Biotec B.V. and Co. KG, Sartorius AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cell freezing media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell freezing media market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Serum-containing Freezing Media
    • Serum-free Freezing Media
    • Protein-free Freezing Media
    • Chemically-defined Freezing Media
  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Mammalian Cell Freezing Media
    • Stem Cell Freezing Media
    • Primary Cell Freezing Media
    • Insect Cell Freezing Media
    • Microbial Cell Freezing Media
  • Cryoprotectant Type Insights (Revenue, USD Bn, 2020 - 2032)
    • DMSO-containing Media
    • DMSO-free Media
    • Glycerol-based Media
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Stem Cell Preservation
    • Tissue Preservation
    • Sperm Freezing
    • Oocyte and Embryo Freezing
    • Regenerative Medicine
  • Formulation Insights (Revenue, USD Bn, 2020 - 2032)
    • Ready-to-use Formulations
    • Custom/Research-grade Formulations
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Diagnostic Laboratories
    • Cell Banks and Biorepositories
    • Contract Research Organizations (CROs)
    • Others (Academic and Research Institutes, etc.)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific Inc.
    • Cytiva (Danaher Corporation)
    • Merck KGaA (Sigma-Aldrich)
    • Lonza Group AG
    • STEMCELL Technologies Inc.
    • BioLife Solutions Inc.
    • Corning Incorporated
    • HiMedia Laboratories Pvt. Ltd.
    • FUJIFILM Irvine Scientific Inc.
    • MP Biomedicals LLC
    • AMSBIO (AMS Biotechnology)
    • Nacalai Tesque Inc.
    • Cell Applications Inc.
    • Miltenyi Biotec B.V. and Co. KG
    • Sartorius AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cell Freezing Media Market, By Product Type
    • Global Cell Freezing Media Market, By Cell Type
    • Global Cell Freezing Media Market, By Cryoprotectant Type
    • Global Cell Freezing Media Market, By Application
    • Global Cell Freezing Media Market, By Formulation
    • Global Cell Freezing Media Market, By End User
    • Global Cell Freezing Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Cell Freezing Media Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Serum-containing Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Serum-free Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Protein-free Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemically-defined Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Cell Freezing Media Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mammalian Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Stem Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Primary Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insect Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microbial Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cell Freezing Media Market, By Cryoprotectant Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • DMSO-containing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • DMSO-free Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Glycerol-based Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Freezing Media Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sperm Freezing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oocyte and Embryo Freezing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Freezing Media Market, By Formulation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Ready-to-use Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Custom/Research-grade Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cell Freezing Media Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals and Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell Banks and Biorepositories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Academic and Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Cell Freezing Media Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytiva (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA (Sigma-Aldrich)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • STEMCELL Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioLife Solutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Irvine Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MP Biomedicals LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AMSBIO (AMS Biotechnology)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nacalai Tesque Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cell Applications Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Miltenyi Biotec B.V. and Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sartorius AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About Us